Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK PM Warns Of Tougher Measures Ahead, Calls For "Maximum Vigilance"

Mon, 11th Jan 2021 16:25

(Alliance News) - UK Prime Minister Boris Johnson has warned that tougher lockdown measures may be needed as he announced that around 2.4 million vaccines for Covid-19 have now been put in people's arms in the UK.

The prime minister stressed "now is the moment for maximum vigilance" amid increasing calls for tougher lockdown restrictions as case rates soar in several parts of the country.

During a visit to a vaccine centre in Ashton Gate Stadium, Bristol, the prime minister said: "We're going to keep the rules under constant review.

"Where we have to tighten them, we will.

"We have rules in place already which, if they are properly followed, we believe can make a huge, huge difference.

"It's now that people need to focus...when they're out shopping, whether they're buying cups of coffee in the park or whatever it happens to be, they need to think about spreading the disease."

Johnson said that "more important than us just pushing out new rules", people should follow existing guidance.

"In supermarkets, people need to be keeping their distance, making sure that they're wearing masks, doing the right thing.

"We need to enforce the rules in supermarkets. When people are getting takeaway drinks, in cafes, then they need to avoid spreading the disease there, avoid mingling too much.

"Now is the moment for maximum vigilance, maximum observance of the rules.

"Of course, if we feel that things are not being properly observed then we may have to do more."

Turning to vaccines, the prime minister said roughly 40% of the 80-year-olds in the UK have now been vaccinated, with around 23% of the elderly residents of care homes having been inoculated.

He said around two million people overall have received a vaccine and "maybe a bit more".

He added: "We're at about 2.4 million jabs all in across the whole of the UK."

Among those calling for tougher lockdown rules is Labour leader Keir Starmer, who told reporters the country is "at the most serious stage" of the pandemic "and that calls for the most serious restrictions".

Starmer said: "There probably is more that we could do.

"An example is the question of whether nurseries should be open."

It comes as Chris Whitty, England's chief medical officer, warned the UK has not yet hit the peak of the current wave of Covid-19 infections, with the next few weeks being "the worst" of the pandemic for the NHS.

He said the vaccine rollout offered hope that lockdown restrictions could be lifted in the coming months but described the current UK death and case rate as an "appalling situation".

During a BBC phone-in on the current high case rates, he said: "I don't think we're yet at the peak, I'm afraid.

"I think we will be at the peak if everybody can double down and absolutely minimise their contacts.

"The point of the lockdown is to bring that forward, but it only works if everyone really thinks about every individual interaction they have and try and minimise them."

Whitty said the new variant of coronavirus was causing a "significant problem", telling BBC Breakfast: "We will get through together but at this point in time we're at the worst point in the epidemic for the UK."

Currently, around one in 50 people in England is infected.

Whitty said: "There's a very high chance that if you meet someone unnecessarily they will have Covid."

He added: "This is the most dangerous time we have really had in terms of numbers into the NHS at this particular time."

Asked if coronavirus is being spread outdoors, Whitty said the risks were much lower than for indoors, but said problems could occur if people gathered in groups, such as huddled round a market stall.

Pressed on whether people should wear masks in all outdoor settings, he said the most important thing was actually that people stayed home unless their journey was essential.

"I think that the much more important thing is that people should not be leaving their home unless they absolutely have to," he said.

"And where they do, try and keep their distance from people."

He added: "In a sense tinkering with the rules may be useful, but the far more important thing is that everybody abides by the spirit of the rules that are there at the moment."

It comes as seven mass vaccination centres open across England in a drive to ramp up the rollout of coronavirus vaccines from Pfizer Inc and AstraZeneca PLC.

The government aims to hit a target of vaccinating around 15 million people at highest risk of death and severe disease by the middle of February.

The new centres – including at a football stadium and a tennis club – will be joined later this week by hundreds more GP-led and hospital services along with the first pharmacy-led pilot sites, taking the total in England to around 1,200.

Overall there will be 2,700 vaccine sites across the UK, according to the government vaccine rollout plan.

The document sets out plans to vaccinate at least two million people a week, with ministers pledging that "tens of millions will be immunised by spring".

It also suggests that "those delivering key public services" and others at high risk of exposure could be next in line for the vaccine once the at-risk priority groups have been vaccinated.

By Jane Kirby, PA Health Editor

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more
8 Apr 2024 07:43

LONDON BRIEFING: Astra hails neurology data; CVS flags cyberattack

(Alliance News) - London's FTSE 100 is called to open a touch higher on Monday, ahead of an interest rate decision in the eurozone and a US inflation reading later in the week.

Read more
8 Apr 2024 07:02

AstraZeneca's Enhurtu cancer gets US green light for adult patients

(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.

Read more
8 Apr 2024 06:53

TOP NEWS: AstraZeneca's, Daiichi's Enhertu receives US FDA approval

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Saturday announced that the US Food & Drug Administration has approved their cancer drug conjugate for patients with metastatic HER2-positive solid tumours.

Read more
5 Apr 2024 09:42

AstraZeneca makes "breakthrough" in treating small cell lung cancer

(Alliance News) - AstraZeneca PLC on Friday reported positive results relating to its Imfinzi cancer treatment in phase III trials.

Read more
5 Apr 2024 07:50

LONDON BRIEFING: Shell to book USD600 million first-quarter write-off

(Alliance News) - London's FTSE 100 is called to open lower on Friday, with hawkish remarks from Federal Reserve policymakers and fears of ratcheting Middle East tensions giving investors little to cheer about ahead of the latest US jobs data.

Read more
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.